Actively Recruiting
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Led by Vanda Pharmaceuticals · Updated on 2025-09-17
160
Participants Needed
5
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
CONDITIONS
Official Title
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be at least 18 years of age of either gender and any race.
- Provide written informed consent and sign the HIPAA form.
- Be willing and able to follow all instructions and attend all study visits.
You will not qualify if you...
- Use of any of the disallowed medications during the washout and study period.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Vanda Investigational Site
Newport Beach, California, United States, 92663
Actively Recruiting
2
Vanda Investigational Site
Andover, Massachusetts, United States, 01810
Not Yet Recruiting
3
Vanda Investigational Site
Shelby, North Carolina, United States, 28150
Not Yet Recruiting
4
Vanda Investigational Site
Memphis, Tennessee, United States, 38119
Actively Recruiting
5
Vanda Investigational Site
Lynchburg, Virginia, United States, 24502
Not Yet Recruiting
Research Team
V
Vanda Pharmaceuticals
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here